249 related articles for article (PubMed ID: 17588750)
1. Synthesis and binding affinity of new pyrazole and isoxazole derivatives as potential atypical antipsychotics.
Barceló M; Raviña E; Masaguer CF; Domínguez E; Areias FM; Brea J; Loza MI
Bioorg Med Chem Lett; 2007 Sep; 17(17):4873-7. PubMed ID: 17588750
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and binding affinity of potential atypical antipsychotics with the tetrahydroquinazolinone motif.
Carro L; Raviña E; Domínguez E; Brea J; Loza MI; Masaguer CF
Bioorg Med Chem Lett; 2009 Nov; 19(21):6059-62. PubMed ID: 19796944
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, binding affinity, and molecular docking analysis of new benzofuranone derivatives as potential antipsychotics.
Aranda R; Villalba K; Raviña E; Masaguer CF; Brea J; Areias F; Domínguez E; Selent J; López L; Sanz F; Pastor M; Loza MI
J Med Chem; 2008 Oct; 51(19):6085-94. PubMed ID: 18783204
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, binding affinity and SAR of new benzolactam derivatives as dopamine D3 receptor ligands.
Ortega R; Raviña E; Masaguer CF; Areias F; Brea J; Loza MI; López L; Selent J; Pastor M; Sanz F
Bioorg Med Chem Lett; 2009 Mar; 19(6):1773-8. PubMed ID: 19217777
[TBL] [Abstract][Full Text] [Related]
5. Conformationally constrained butyrophenones with mixed dopaminergic (D(2)) and serotoninergic (5-HT(2A), 5-HT(2C)) affinities: synthesis, pharmacology, 3D-QSAR, and molecular modeling of (aminoalkyl)benzo- and -thienocycloalkanones as putative atypical antipsychotics.
Raviña E; Negreira J; Cid J; Masaguer CF; Rosa E; Rivas ME; Fontenla JA; Loza MI; Tristán H; Cadavid MI; Sanz F; Lozoya E; Carotti A; Carrieri A
J Med Chem; 1999 Jul; 42(15):2774-97. PubMed ID: 10425088
[TBL] [Abstract][Full Text] [Related]
6. Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.
Campiani G; Butini S; Fattorusso C; Catalanotti B; Gemma S; Nacci V; Morelli E; Cagnotto A; Mereghetti I; Mennini T; Carli M; Minetti P; Di Cesare MA; Mastroianni D; Scafetta N; Galletti B; Stasi MA; Castorina M; Pacifici L; Vertechy M; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2004 Jan; 47(1):143-57. PubMed ID: 14695828
[TBL] [Abstract][Full Text] [Related]
7. Discovery of a new class of potential multifunctional atypical antipsychotic agents targeting dopamine D3 and serotonin 5-HT1A and 5-HT2A receptors: design, synthesis, and effects on behavior.
Butini S; Gemma S; Campiani G; Franceschini S; Trotta F; Borriello M; Ceres N; Ros S; Coccone SS; Bernetti M; De Angelis M; Brindisi M; Nacci V; Fiorini I; Novellino E; Cagnotto A; Mennini T; Sandager-Nielsen K; Andreasen JT; Scheel-Kruger J; Mikkelsen JD; Fattorusso C
J Med Chem; 2009 Jan; 52(1):151-69. PubMed ID: 19072656
[TBL] [Abstract][Full Text] [Related]
8. Conformationally constrained butyrophenones with affinity for dopamine (D(1), D(2), D(4)) and serotonin (5-HT(2A), 5-HT(2B), 5-HT(2C)) receptors: synthesis of aminomethylbenzo[b]furanones and their evaluation as antipsychotics.
Raviña E; Casariego I; Masaguer CF; Fontenla JA; Montenegro GY; Rivas ME; Loza MI; Enguix MJ; Villazon M; Cadavid MI; Demontis GC
J Med Chem; 2000 Nov; 43(24):4678-93. PubMed ID: 11101359
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of a series of aminoalkyl-tetralones and tetralols as dual dopamine/serotonin ligands.
Carro L; Torrado M; Raviña E; Masaguer CF; Lage S; Brea J; Loza MI
Eur J Med Chem; 2014 Jan; 71():237-49. PubMed ID: 24316025
[TBL] [Abstract][Full Text] [Related]
10. Serotonin 5-HT2 receptor, dopamine D2 receptor, and alpha 1 adrenoceptor antagonists. Conformationally flexible analogues of the atypical antipsychotic sertindole.
Andersen K; Liljefors T; Hyttel J; Perregaard J
J Med Chem; 1996 Sep; 39(19):3723-38. PubMed ID: 8809161
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and biological evaluation of new quinazoline and cinnoline derivatives as potential atypical antipsychotics.
Alvarado M; Barceló M; Carro L; Masaguer CF; Raviña E
Chem Biodivers; 2006 Jan; 3(1):106-17. PubMed ID: 17193223
[TBL] [Abstract][Full Text] [Related]
12. Novel atypical antipsychotic agents: rational design, an efficient palladium-catalyzed route, and pharmacological studies.
Campiani G; Butini S; Fattorusso C; Trotta F; Gemma S; Catalanotti B; Nacci V; Fiorini I; Cagnotto A; Mereghetti I; Mennini T; Minetti P; Di Cesare MA; Stasi MA; Di Serio S; Ghirardi O; Tinti O; Carminati P
J Med Chem; 2005 Mar; 48(6):1705-8. PubMed ID: 15771414
[TBL] [Abstract][Full Text] [Related]
13. Novel, highly potent, selective 5-HT2A/D2 receptor antagonists as potential atypical antipsychotics.
Lee T; Robichaud AJ; Boyle KE; Lu Y; Robertson DW; Miller KJ; Fitzgerald LW; McElroy JF; Largent BL
Bioorg Med Chem Lett; 2003 Feb; 13(4):767-70. PubMed ID: 12639577
[TBL] [Abstract][Full Text] [Related]
14. Searching for multi-target antipsychotics: Discovery of orally active heterocyclic N-phenylpiperazine ligands of D2-like and 5-HT1A receptors.
Neves G; Menegatti R; Antonio CB; Grazziottin LR; Vieira RO; Rates SM; Noël F; Barreiro EJ; Fraga CA
Bioorg Med Chem; 2010 Mar; 18(5):1925-35. PubMed ID: 20153652
[TBL] [Abstract][Full Text] [Related]
15. Butyrophenone analogues in the carbazole series: synthesis and determination of affinities at D2 and 5-HT2A receptors.
Masaguer CF; Formoso E; Raviña E; Tristán H; Loza MI; Rivas E; Fontenla JA
Bioorg Med Chem Lett; 1998 Dec; 8(24):3571-6. PubMed ID: 9934473
[TBL] [Abstract][Full Text] [Related]
16. Butyrophenone analogues in the carbazole series as potential atypical antipsychotics: synthesis and determination of affinities at D(2), 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Masaguer CF; Raviña E; Fontenla JA; Brea J; Tristán H; Loza MI
Eur J Med Chem; 2000 Jan; 35(1):83-95. PubMed ID: 10733606
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and binding affinity of novel 3-aminoethyl-1-tetralones, potential atypical antipsychotics.
Alvarado M; Coelho A; Masaguer CF; Raviña E; Brea J; Padín JF; Loza MI
Bioorg Med Chem Lett; 2005 Jun; 15(12):3063-6. PubMed ID: 15878662
[TBL] [Abstract][Full Text] [Related]
18. 2,5-Disubstituted pyridines: the discovery of a novel series of 5-HT2A ligands.
Wilson KJ; van Niel MB; Cooper L; Bloomfield D; O'Connor D; Fish LR; MacLeod AM
Bioorg Med Chem Lett; 2007 May; 17(9):2643-8. PubMed ID: 17314044
[TBL] [Abstract][Full Text] [Related]
19. 1-cinnamyl-4-(2-methoxyphenyl)piperazines: synthesis, binding properties, and docking to dopamine (D(2)) and serotonin (5-HT(1A)) receptors.
Penjisević J; Sukalović V; Andrić D; Kostić-Rajacić S; Soskić V; Roglić G
Arch Pharm (Weinheim); 2007 Sep; 340(9):456-65. PubMed ID: 17763374
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro pharmacological evaluation of a new series of 5-HT1A 5-HT2A and 5-HT2C receptor ligands containing a norbornene nucleus.
Fiorino F; Severino B; De Angelis F; Perissutti E; Magli E; Frecentese F; Esposito A; Massarelli P; Nencini C; Viti B; Santagada V; Caliendo G
Pharmazie; 2009 Sep; 64(9):555-64. PubMed ID: 19827295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
